Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Isett

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biorxiv : the Preprint Server for Biology|April 10, 2026
CosMxScope: Scalable Reconstruction and Digital Pathology Integration of Imaging-Based Spatial Transcriptomics DataJie Chen, Brian Isett, Qiangqiang Gu, et al.
JCI Insight|August 8, 2024
Psoriatic arthritis subtypes are phenocopied in humanized miceChristopher T Ritchlin, Javier Rangel-Moreno, Delaney Martino, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Identification of tumor-intrinsic drivers of immune exclusion in acral melanomaRyan C Augustin, Sarah Newman, Aofei Li, et al.
Journal for Immunotherapy of Cancer|October 19, 2023
Identification of tumor-intrinsic drivers of immune exclusion in acral melanomaRyan C Augustin, Sarah Newman, Aofei Li, et al.
Journal for Immunotherapy of Cancer|June 15, 2025
Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinomaRebekah E Dadey, Ruxuan Li, Jake Griner, et al.
Science Translational Medicine|October 11, 2023
Donor-derived regulatory dendritic cell infusion modulates effector CD8<sup>+</sup> T cell and NK cell responses after liver transplantationLillian M Tran, Camila Macedo, Alan F Zahorchak, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Oral Oncology|November 10, 2025
Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancerRose Doerfler, Jie Chen, Carl Kim, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Integrating Artificial Intelligence-Driven Digital Pathology and Genomics to Establish Patient-Derived Organoids as a Novel Alternative Model for Drug Response in Head and Neck CancerRose Doerfler, Jie Chen, Carl Kim, et al.
The Oncologist|October 25, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biorxiv : the Preprint Server for Biology|April 10, 2026
CosMxScope: Scalable Reconstruction and Digital Pathology Integration of Imaging-Based Spatial Transcriptomics DataJie Chen, Brian Isett, Qiangqiang Gu, et al.
JCI Insight|August 8, 2024
Psoriatic arthritis subtypes are phenocopied in humanized miceChristopher T Ritchlin, Javier Rangel-Moreno, Delaney Martino, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Identification of tumor-intrinsic drivers of immune exclusion in acral melanomaRyan C Augustin, Sarah Newman, Aofei Li, et al.
Journal for Immunotherapy of Cancer|October 19, 2023
Identification of tumor-intrinsic drivers of immune exclusion in acral melanomaRyan C Augustin, Sarah Newman, Aofei Li, et al.
Journal for Immunotherapy of Cancer|June 15, 2025
Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinomaRebekah E Dadey, Ruxuan Li, Jake Griner, et al.
Science Translational Medicine|October 11, 2023
Donor-derived regulatory dendritic cell infusion modulates effector CD8<sup>+</sup> T cell and NK cell responses after liver transplantationLillian M Tran, Camila Macedo, Alan F Zahorchak, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Oral Oncology|November 10, 2025
Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancerRose Doerfler, Jie Chen, Carl Kim, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Integrating Artificial Intelligence-Driven Digital Pathology and Genomics to Establish Patient-Derived Organoids as a Novel Alternative Model for Drug Response in Head and Neck CancerRose Doerfler, Jie Chen, Carl Kim, et al.
The Oncologist|October 25, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsMatthew K Nguyen, Mark Jelinek, Arjun Singh, et al.
Pageof 2